L-selectin ligands in skin: Expression in lesional skin of patients with cutaneous T-cell lymphoma and in vitro mechanism of stimulation of adhesion to ICAM-1 and fibronectin.

被引：0
|
作者：
Hwang, ST
Singer, M
Giblin, PA
Simon, SI
Rosen, SD
机构：
[1] UNIV CALIF SAN FRANCISCO,DEPT ANAT,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT DERMATOL,SAN FRANCISCO,CA 94143
[3] BAYLOR COLL MED,DEPT PEDIAT,SECT LEUKOCYTE BIOL,HOUSTON,TX 77030
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1996年 / 106卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：777 / 777
页数：1
相关论文
共 27 条
  • [21] Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma (vol 138, pg 325, 2002)
    Breneman, D
    Stevens, VJ
    ARCHIVES OF DERMATOLOGY, 2002, 138 (10) : 1386 - 1386
  • [22] TNF-α Induces Endothelial Cell Expression of Intercellular Adhesion Molecule-1 (ICAM-1) Required for Recruitment of Antigen-Primed CD8 T Cells to Mediate Responses in the Skin
    Kish, Danielle
    Baldwin, William
    Fairchild, Robert
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [23] Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)
    Quiros, PA
    Jones, GW
    Kacinski, BM
    Braverman, IM
    Heald, PW
    Edelson, RL
    Wilson, LD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (05): : 1027 - 1035
  • [24] ANALYSIS OF T-CELL STIMULATION BY SUPERANTIGEN PLUS MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES OR BY CD3 MONOCLONAL-ANTIBODY - COSTIMULATION BY PURIFIED ADHESION LIGANDS VCAM-1, ICAM-1, BUT NOT ELAM-1
    VANSEVENTER, GA
    NEWMAN, W
    SHIMIZU, Y
    NUTMAN, TB
    TANAKA, Y
    HORGAN, KJ
    GOPAL, TV
    ENNIS, E
    OSULLIVAN, D
    GREY, H
    SHAW, S
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (04): : 901 - 913
  • [25] Oral LBH589, a novel histone deacetylase inhibitor, treatment of patients with cutaneous T-cell lymphoma (CTCL). Changes in skin gene expression profiles related to clinical response following therapy
    Prince, H. Miles
    Ellis, Leigh
    Johnstone, Ricky
    McCormack, Christopher
    McArthur, Grant
    Davison, Jill
    Atadja, Peter W.
    Kwong, Celena
    Dugan, Margaret
    Culver, Kenneth W.
    CANCER RESEARCH, 2006, 66 (08)
  • [26] LBH589, a novel histone deacetylase inhibitor (HDACi), treatment of patients with cutaneous T-cell lymphoma (CTCL). Changes in skin gene expression profiles related to clinical response following therapy.
    Prince, H. M.
    George, D. J.
    Johnstone, R.
    Williams-Truax, R.
    Atadja, P.
    Zhao, C.
    Dugan, M.
    Culver, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 422S - 422S
  • [27] LBH589, a novel deacetylase inhibitor (DACi), treatment of patients with cutaneous T-cell lymphoma (CTCL). Skin gene expression profiles in the first 24 hours related to clinical response following therapy.
    Prince, Miles
    George, D. J.
    Johnstone, R.
    McCormack, C.
    Ellis, L.
    Williams-Truax, R.
    Atadja, P.
    Zhao, C.
    Dugan, M.
    Culver, K.
    BLOOD, 2006, 108 (11) : 767A - 767A
123